In glucose-limited conditions, digestive system tumor cells may shift toward lipid oxidation or glutamine catabolism, diminishing the efficacy of glycolysis-targeting agents and, paradoxically, rendering PKM2 inhibition survival-promoting (43, 82). The gene discussed is PKM; the disease is neoplasm.